Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities
The term "microbiota" refers to the microbial community occupying a specific habitat with defined physical and chemical properties and forming specific ecological niches. The adult intestinal microbiota is diverse. It mainly consists of bacteria of Bacteroidetes and ...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2023-03-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2889 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227557349621760 |
|---|---|
| author | A. V. Gorbenko Y. P. Skirdenko K. A. Andreev M. M. Fedorin N. A. Nikolaev M. A. Livzan |
| author_facet | A. V. Gorbenko Y. P. Skirdenko K. A. Andreev M. M. Fedorin N. A. Nikolaev M. A. Livzan |
| author_sort | A. V. Gorbenko |
| collection | DOAJ |
| description | The term "microbiota" refers to the microbial community occupying a specific habitat with defined physical and chemical properties and forming specific ecological niches. The adult intestinal microbiota is diverse. It mainly consists of bacteria of Bacteroidetes and Firmicutes types. The link between the gut microbiota and cardiovascular disease (CVD) is being actively discussed. Rapid progress in this field is explained by the development of new generation sequencing methods and the use of sterile gut mice in experiments. More and more data are being published about the influence of microbiota on the development and course of hypertension, coronary heart disease (IHD), myocardial hypertrophy, chronic heart failure (CHF) and atrial fibrillation (AF). Diet therapy, antibacterial drugs, pro- and prebiotics are successfully used as tools to correct the structure of the gut microbiota of the macroorganism. Correction of gut microbiota in an experiment on rats with coronary occlusion demonstrates a significant reduction in necrotic area. A study involving patients suffering from CHF reveals a significant reduction in the level of uric acid, highly sensitive C-reactive protein, and creatinine. In addition to structural and laboratory changes in patients with CVD when modifying the microbiota of the gut, also revealed the effect on the course of arterial hypertension. Correction of gut microbiota has a beneficial effect on the course of AF. We assume that further active study of issues of influence and interaction of gut microbiota and macroorganism may in the foreseeable future make significant adjustments in approaches to treatment of such patients. |
| format | Article |
| id | doaj-art-1bec47fa2acc4478a6495c448c677577 |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2023-03-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-1bec47fa2acc4478a6495c448c6775772025-08-23T10:00:35ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532023-03-01191586410.20996/1819-6446-2023-01-032100Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction PossibilitiesA. V. Gorbenko0Y. P. Skirdenko1K. A. Andreev2M. M. Fedorin3N. A. Nikolaev4M. A. Livzan5Omsk State Medical UniversityOmsk State Medical UniversityOmsk State Medical UniversityOmsk State Medical UniversityOmsk State Medical UniversityOmsk State Medical UniversityThe term "microbiota" refers to the microbial community occupying a specific habitat with defined physical and chemical properties and forming specific ecological niches. The adult intestinal microbiota is diverse. It mainly consists of bacteria of Bacteroidetes and Firmicutes types. The link between the gut microbiota and cardiovascular disease (CVD) is being actively discussed. Rapid progress in this field is explained by the development of new generation sequencing methods and the use of sterile gut mice in experiments. More and more data are being published about the influence of microbiota on the development and course of hypertension, coronary heart disease (IHD), myocardial hypertrophy, chronic heart failure (CHF) and atrial fibrillation (AF). Diet therapy, antibacterial drugs, pro- and prebiotics are successfully used as tools to correct the structure of the gut microbiota of the macroorganism. Correction of gut microbiota in an experiment on rats with coronary occlusion demonstrates a significant reduction in necrotic area. A study involving patients suffering from CHF reveals a significant reduction in the level of uric acid, highly sensitive C-reactive protein, and creatinine. In addition to structural and laboratory changes in patients with CVD when modifying the microbiota of the gut, also revealed the effect on the course of arterial hypertension. Correction of gut microbiota has a beneficial effect on the course of AF. We assume that further active study of issues of influence and interaction of gut microbiota and macroorganism may in the foreseeable future make significant adjustments in approaches to treatment of such patients.https://www.rpcardio.online/jour/article/view/2889microbiotacorrectiondietprobioticsprebioticscardiovascular disease |
| spellingShingle | A. V. Gorbenko Y. P. Skirdenko K. A. Andreev M. M. Fedorin N. A. Nikolaev M. A. Livzan Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities Рациональная фармакотерапия в кардиологии microbiota correction diet probiotics prebiotics cardiovascular disease |
| title | Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities |
| title_full | Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities |
| title_fullStr | Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities |
| title_full_unstemmed | Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities |
| title_short | Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities |
| title_sort | microbiota and cardiovascular diseases mechanisms of influence and correction possibilities |
| topic | microbiota correction diet probiotics prebiotics cardiovascular disease |
| url | https://www.rpcardio.online/jour/article/view/2889 |
| work_keys_str_mv | AT avgorbenko microbiotaandcardiovasculardiseasesmechanismsofinfluenceandcorrectionpossibilities AT ypskirdenko microbiotaandcardiovasculardiseasesmechanismsofinfluenceandcorrectionpossibilities AT kaandreev microbiotaandcardiovasculardiseasesmechanismsofinfluenceandcorrectionpossibilities AT mmfedorin microbiotaandcardiovasculardiseasesmechanismsofinfluenceandcorrectionpossibilities AT nanikolaev microbiotaandcardiovasculardiseasesmechanismsofinfluenceandcorrectionpossibilities AT malivzan microbiotaandcardiovasculardiseasesmechanismsofinfluenceandcorrectionpossibilities |